ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,291.34
0.15%
US Tech 100
18,200.00
0.41%
Dow Jones
38,711.29
0.36%
Brent Oil
77.33
0.29%
Bitcoin
70,465.29
-0.14%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. 60 Degrees Pharmaceuticals Inc (SXTP) Quote

60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals Inc (SXTP)

NASDAQ
0.2975
0.0025
(0.85%)
Closed June 04 4:00PM
Delayed by 15 minutes
0.298
0.0005
(0.17%)
After Hours: 7:32PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.298
Bid
0.2803
Ask
0.298
Volume
255,443
0.285 Day's Range 0.306
0.2011 52 Week Range 8.65
Market Cap
1.74M
Previous Close
0.295
Open
0.304
Last Trade
80
@
0.298
Last Trade Time
Financial Volume
$ 75,353
VWAP
0.294988
Average Volume (3m)
348,752
Shares Outstanding
5,799,535
Dividend Yield
-
PE Ratio
-0.46
Earnings Per Share (EPS)
-0.65
Revenue
254k
Net Profit
-3.77M

About 60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Its lead product, ARAKODA (tafenoquine), is an antimalar... 60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Its lead product, ARAKODA (tafenoquine), is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years and older. The Company's pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases; new products that contain the Arakoda regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. The ARAKODA regimen of tafenoquine is in Phase II study data in patients with mild-moderate COVID-19 disease. It is also planning a clinical study to assess the utility of ARAKODA as a treatment for human babesiosis. The Company is also developing Celgosivir for the treatment of COVID-19, respiratory syncytial virus (RSV), and dengue. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
60degreespharma.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
60 Degrees Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SXTP. The last closing price for 60 Degrees Pharmaceuticals was $0.30. Over the last year, 60 Degrees Pharmaceuticals shares have traded in a share price range of $ 0.2011 to $ 8.65.

60 Degrees Pharmaceuticals currently has 5,799,535 shares outstanding. The market capitalization of 60 Degrees Pharmaceuticals is $1.74 million. 60 Degrees Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.46.

SXTP Latest News

More News

Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind

60 Degrees Pharmaceuticals has entered an agreement with Tufts Medical Center to conduct a clinical trial that will evaluate the safety and efficacy of tafenoquine for the treatment of babesiosis...

May 30 2024
GlobeNewswire Inc.

60 Degrees Pharmaceuticals Funds Babesia spp Testing in Chronic Fatigue Patient Samples in NC State College of Veterinary Medicine Study

Long-term chronic fatigue syndrome (CFS) symptoms can be triggered by certain prior acute infectionsProminent researchers/clinicians in the tick-borne disease scientific community postulate that...

May 20 2024
GlobeNewswire Inc.

60 Degrees Pharmaceuticals Announces First Quarter 2024 Results

Q1 2024 net product revenues increased 515% year-over-year to $105.7 thousand.Gross profit increased from ($55.9 thousand) to $51.0 thousand. WASHINGTON, May 15, 2024 (GLOBE NEWSWIRE) -- 60...

May 15 2024
GlobeNewswire Inc.

60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial of Tafenoquine in Babesiosis in Letter to Journal of Infectious Diseases

The U.S. medical scientific community is calling for clinical studies to expand shared understanding of babesiosis, an emerging tick-borne illness.The upcoming 60 Degrees Pharma clinical trial of...

May 08 2024
GlobeNewswire Inc.

60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required

Trial planning and execution to proceed as planned WASHINGTON, May 02, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company...

May 02 2024
GlobeNewswire Inc.

60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis

Study to be conducted by North Carolina State University in 2024Standard of care fails in 20 percent of cases and drug resistance is a problemStandard of care is expensive WASHINGTON, April 03...

April 03 2024
GlobeNewswire Inc.

60 Degrees Pharmaceuticals Announces Communication from the FDA of Intention to Respond to Tafenoquine-Babesiosis Trial Protocol Submission in April, 2024

WASHINGTON, March 14, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc., (NASDAQ: SXTP, SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), a pharmaceutical company focused on...

March 14 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 20 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.007-2.295081967210.3050.30970.264639570.28287583CS
40.095647.2332015810.20240.34150.20136511810.27307247CS
120.027910.32950758980.27010.34150.20113487520.26408308CS
26-0.3589-54.6354087380.65691.530.20115654220.69498463CS
52-3.452-92.05333333333.758.650.20115562871.94031169CS
156-3.452-92.05333333333.758.650.20115562871.94031169CS
260-3.452-92.05333333333.758.650.20115562871.94031169CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLGOMicroAlgo Inc
$ 11.98
(667.95%)
185.75M
VSTEVast Renewable Ltd
$ 4.49
(79.60%)
9.96M
SOBRSOBR Safe Inc
$ 0.4507
(71.04%)
267.96M
MFImF International Ltd
$ 1.315
(41.40%)
2.02M
DHACUDigital Health Acquisition Corporation
$ 23.06
(40.61%)
3.95k
JDZGJIADE Ltd
$ 1.72
(-86.21%)
14.65M
NDRAENDRA Life Sciences Inc
$ 0.086
(-60.37%)
71.57M
ALBTAvalon GloboCare Corporation
$ 0.85
(-30.89%)
5.97M
EQEquillium Inc
$ 1.05
(-28.57%)
10.83M
ATGLAlpha Technology Group Limited
$ 2.86
(-28.32%)
103.33k
SOBRSOBR Safe Inc
$ 0.4507
(71.04%)
267.96M
MLGOMicroAlgo Inc
$ 11.98
(667.95%)
185.75M
SQQQProShares UltraPro Short QQQ
$ 9.86
(-0.70%)
125.46M
FFIEFaraday Future Intelligent Electric Inc
$ 0.557
(-10.85%)
101.47M
CRKNCrown Electrokinetics Corporation
$ 0.1044
(-11.45%)
92.01M

SXTP Discussion

View Posts
The Night Stalker The Night Stalker 5 days ago
https://stockcharts.com/h-sc/ui?s=SXTP&p=D&yr=0&mn=5&dy=10&id=p24986097784&listNum=23&a=1113701411
👍️0
The Night Stalker The Night Stalker 5 days ago
https://stockcharts.com/h-sc/ui?s=sxtp&p=W&yr=1&mn=6&dy=0&id=p24986097784&listNum=23&a=1113701411
👍️0
The Night Stalker The Night Stalker 5 days ago
need .29 break
👍️0
The Night Stalker The Night Stalker 6 days ago
https://stockcharts.com/h-sc/ui?s=SXTP&p=D&yr=0&mn=5&dy=10&id=p24986097784&listNum=23&a=1113701411
👍️0
The Night Stalker The Night Stalker 6 days ago
wants eod push
👍️0
The Night Stalker The Night Stalker 1 week ago
goal is to see 1 here and buy .AZTR before the run
👍️0
The Night Stalker The Night Stalker 1 week ago
now everyone wants the next big dick LUCY. building consistent volume as volume increased on friday
👍️0
The Night Stalker The Night Stalker 1 week ago
thanks, nevermind the fuckface seller at .34 jee sell before the big breakout. this an AZTR here
👍️0
The Night Stalker The Night Stalker 1 week ago
thanks, nevermind the fuckface seller at .34 jee sell before the big breakout. this an AZTR here
👍️0
WARHAMMER WARHAMMER 1 week ago
Oh yeah? Good
👍️0
The Night Stalker The Night Stalker 2 weeks ago
biotech frenzy next
👍️0
The Night Stalker The Night Stalker 2 weeks ago
https://stockcharts.com/h-sc/ui?s=sxtp&p=30&yr=0&mn=0&dy=15&id=p24986097784&listNum=23&a=1113701411
👍️0
The Night Stalker The Night Stalker 2 weeks ago
https://stockcharts.com/h-sc/ui?s=sxtp&p=W&yr=1&mn=6&dy=0&id=p24986097784&listNum=23&a=1113701411
👍️0
The Night Stalker The Night Stalker 2 weeks ago
https://stockcharts.com/h-sc/ui?s=SXTP&p=D&yr=0&mn=5&dy=10&id=p24986097784&listNum=23&a=1113701411
👍️0
Monksdream Monksdream 2 weeks ago
Fyi link for stocks under 25 cents
https://marketxls.com/screener/333/penny-stocks-under-25-cents
Next day settlement begins May 28
👍️0
The Night Stalker The Night Stalker 2 weeks ago
loaded at .31
👍️0
Monksdream Monksdream 2 weeks ago
SXTP under 25 cents
👍️0
PennyStockTrader2 PennyStockTrader2 1 month ago
Continued to buy as it has stairstepped down now at 25K shares. I definitely expect a nice run at one point and will take profits appropriately though I dont have a specific plan in place yet, I would look to start selling in the .40s, also dependent on what the news is.
👍️0
PennyStockTrader2 PennyStockTrader2 4 months ago
I'd like to wring the neck of management for what they did. Luckily I took some profits in the .80s, only to see it drop to .30 and below where I have picked up a little and would buy more at .29. At this price it should be safely priced. When it spikes back up I dont know.
👍️0
Awl416 Awl416 4 months ago
60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
👍️0
PennyStockTrader2 PennyStockTrader2 4 months ago
Taken on new position in SXTP on this downdraft. This is more of a shorter term trade looking for it to go back over a buck, lets see.
👍️0
DERBYBLOOD DERBYBLOOD 5 months ago
WHO is the idiot trying to sell 78K shares @ $1.09 ALL AT ONCE ??? Break UP that sell order genius....Are you TRYING to create a wall / stop a run?
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 5 months ago
$SXTP
https://x.com/hannahadad8890/status/1739964080163541132?s=61
👍️0
TheFinalCD TheFinalCD 5 months ago
https://finviz.com/quote.ashx?t=SXTP&p=d
https://dilutiontracker.com/app/search/SXTP
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 5 months ago
Absolutely agree..
👍️0
81vette 81vette 5 months ago
Has a “thinking about buying” promoters dumping on all 3 right now,once they done,if they don’t destroy it and enough ppl see potential it might go up,has to have excellent financials and astronomical potential for continuation
👍️0
Awl416 Awl416 5 months ago
Wild
👍️0
Awl416 Awl416 5 months ago
Don’t mess with algo’s
👍️0
Awl416 Awl416 5 months ago
Half the float is traded and this about to go red

👍️0
TommyBoyTrader9460 TommyBoyTrader9460 5 months ago
$SXTP
https://x.com/hannahadad8890/status/1737839683814768844?s=61
👍️0
Awl416 Awl416 5 months ago
Algo’s once again ruining a ticker. The spread was as high as .12 yesterday

What a market
👍️0
Muhbruh Muhbruh 6 months ago
$SXTP 19.9% 13Ghttps://t.co/2TGdN884FX pic.twitter.com/5Lizh4wZKG— STOCKS Gambino (@StocksGambino) December 18, 2023
👍️0
Disquisition Disquisition 8 months ago
INSCRUTABLE DUMPING
👍️0
Disquisition Disquisition 9 months ago
INDESCRIBABLE DUMPING
👍️0
Awl416 Awl416 9 months ago
60 Degrees Pharmaceuticals Receives Additional U.S. Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria
👍️0
hazarderk hazarderk 10 months ago
Not when they dilute unlimited
👍️0
Stockexpertpro Stockexpertpro 10 months ago
SXTP News Low Float Recent IPO no resistance above 2.50$
👍️0
AJ Freely AJ Freely 10 months ago
$SXTP - 👆Up 13.7% Pre-Market/ Current Price $2.43
Awarded Canadian Patent Covering Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects
👍️0
Willy Willy 10 months ago
All your predictions are wrong on every board. No one believes anything you post.
👍️0
Pedro2004 Pedro2004 10 months ago
Wow. Down to $2.01 yesterday. -- We'll have to wait for the 10Q to see what type of scam they're pulling.
👍️0
Pedro2004 Pedro2004 10 months ago
I don't see that happening anytime in the near future.
👍️0
hondaboost hondaboost 10 months ago
SXTP, a garbage and scam, that's why everybody is shorting it. Dead Cat!
👍️0
saigai saigai 11 months ago
i think tomorrow will be a good day..only a darn fool would short it here. solid volume and base. i say it runs hard am pre ..we shall see
👍️0
Volcano Volcano 11 months ago
Patience always pay off
👍️0
Triple nickle Triple nickle 11 months ago
Here goes
👍️0
saigai saigai 11 months ago
maybe if folks dont scalp every 2 cent... thats what happens when the confidence in the game is not what it use to be
👍️0
Inve$tor77 Inve$tor77 11 months ago
$SXTP super low float post IPO. Could get interesting.
👍️0
Triple nickle Triple nickle 11 months ago
Bots got it
👍️0
AJ Freely AJ Freely 11 months ago
$SXTP -Up 40% Pre-Market/ Current Price $3.36
Offers a robust range of capital markets and investment banking services to the healthcare community.
IPO on July 12 (Wed)
Super Low Float-near 2 million
👍️0
Harbor6460 Harbor6460 11 months ago
Guess not. 1.00
👍️0

Your Recent History

NASDAQ
SXTP
60 Degrees Pharmaceuticals
BIT
P1BQU3
BNP Paribas Issuance
BIT
P1LBE8
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved